EXELA’s Position on Use of Our Products in Lethal Injections for Capital Punishment

Exela Pharma Sciences believes that providing medicines to alleviate human pain and suffering is one of the noblest undertakings. Making medicines affordable and expediting their availability to the needy is a worthy goal. That is Exela®’s focus and Mission. Exela opposes any use of our products that does not meet our Mission Statement, including the use of Potassium Acetate for lethal injection in capital punishment cases. We have taken actions to ensure our products are only available to those health care providers that use the products for their intended purpose as approved by the FDA.

Exela exists purely to help improve a patient’s life and no medicine we manufacture should ever be used to end a life. We stand with other pharmaceutical manufacturers who have taken similar steps to prevent life-saving medications from being used for capital punishment. We prohibit the purchase of Potassium Acetate Injection by correctional institutions or prisons via direct sale or indirect sale. Our authorized distributors have been notified not to accept any orders for our products from institutions who may use them for indications outside of their intended use and we prohibit sales of Potassium Acetate Injection to retail customers who may in turn resell the product to correctional institutions or prisons.